Is Ourofino SA halal to invest in?

As of September 2026, Ourofino SA OFSA3.SA is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Ourofino SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ourofino SA using these criteria to determine its compliance status.

Can Muslims buy shares of Ourofino SA?

Muslim investors may consider investing in Ourofino SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ourofino SA classified as NOT COVERED?

Musaffa determines the Shariah status of Ourofino SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ourofino SA updated?

The Shariah compliance status of Ourofino SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ourofino SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ourofino SA?

You can check the latest Shariah compliance status of Ourofino SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Ourofino SA. Stock Analysis OFSA3.SA

Brazil Health Care Micro Cap

Ourofino SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The Company’s activities are divided into three categories: production animals; companion animals; and international operations. The production animals segment represents the manufacture and sale in the domestic market of vaccines and veterinary products for animals, including ruminants, poultry, swine and horses. The companion animal segment is responsible for the manufacture and sale of veterinary products for dogs and cats. The Company’s portfolio includes otological, dermatological, nutritional, antibiotic, anti-inflammatory, antiparasitic products, as well as diagnostic kits and disinfectants. The international operations segment represents the production of vaccines and veterinary products for the foreign market, including Mexico and Colombia.

Ourofino SA OFSA3.SA

Last Updated: Sep 11, 12:00 AM·BOVESPA